S0916, MLN1202 in Treating Patients With Bone Metastases

Summary

RATIONALE: Monoclonal antibodies, such MLN1202, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This phase II trial is studying how well MLN1202 works in treating patients with bone metastases.

Timeline

Start

2010-03

Primary completion

2012-12

Completion

2012-12

Drugs

Indications